Equity (Tables) |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Aug. 31, 2026 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Stockholders' Equity Note [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Summary of Estimated Fair Value under Monte-Carlo Simulation Model Assumptions | the Company estimates the fair value using a Monte-Carlo simulation model utilizing the following key assumptions for such awards:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Summary of Restricted Stock Share and Restricted Stock Unit Grants | The following table summarizes the activity for the Company’s restricted stock unit grants, including performance based grants, under the 2021 Plan:
1 Includes 180 thousand time-based and 202 thousand performance-based restricted stock unit awards. 2 For the 2023-2025 performance period, incremental shares earned includes 125 thousand additional shares awarded to participants based on the EBITDA criteria for which actual performance resulted in a payout above target and 41 thousand additional shares awarded to participants based on the Relative TSR criteria for which actual performance resulted in a payout above target. 3 Includes 192 thousand time-based and 373 thousand performance-based restricted stock units. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||